1.Kotloff, KL, et al. Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bulletin of the World Health Organization 1999; 77: 651–666.
2.Von Seidlein, L, et al. A multicentre study of Shigella diarrhoea in six Asian countries: disease burden, clinical manifestations, and microbiology. PLoS Medicine 2006; 3: e353.
3.National Institute of Population Research and Training. Bangladesh demographic and health survey 2007. Dhaka, 2009.
4.Bennish, ML. Potentially lethal complications of shigellosis. Review of Infectious Diseases 1991; 13: S319–324.
5.Bennish, ML, Wojtyniak, BJ. Mortality due to shigellosis: community and hospital data. Review of Infectious Diseases 1991; 13: S245–251.
6.Islam, SS, Shahid, NS. Morbidity and mortality in a diarrhoeal diseases hospital in Bangladesh. Transactions of the Royal Society of Tropical Medicine and Hygiene 1986; 80: 748–752.
7.Chompook, P, et al. Estimating the burden of shigellosis in Thailand: 36-month population-based surveillance study. Bulletin of the World Health Organization 2005; 83: 739–746.
8.Rahaman, MM, et al. An outbreak of dysentery caused by Shigella dysenteriae type 1 on a coral island in the Bay of Bengal. Journal of Infectious Diseases 1975; 132: 15–19.
9.Niyogi, SK, Mitra, U, Dutta, P. Changing patterns of serotypes and antimicrobial susceptibilities of Shigella species isolated from children in Calcutta, India. Japanese Journal of Infectious Diseases 2001; 54: 121–122.
10.Edwards, PR, Ewing, WH. Identification of Enterobacteriaceae, 3rd edn. Minneapolis: Burgess, 1972, 362 pp.
11.Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; 16th informational supplement. M100-S17. Wayne, PA: Clinical and Laboratory Standards Institute, 2007.
13.Sack, DA, Bardhan, PK, Naheed, A. Trends in shigellosis burden of disease in Asia. In: Improving Human Health through Biotechnology: programme and abstracts of the 11th Asian Conference on Diarrhoeal Diseases and Nutrition (11th ASCODD 2006), 8–10 March 2006. Rama Gardens Hotel, Bangkok, Thailand. Bangkok, 2006, p. 15.
14.Cutler, D, Miller, G. The role of public health improvements in health advances: the twentieth-century United States. Demography 2005; 42: 1–22.
15.Koster, FT, et al. Synergistic impact of measles and diarrhoea on nutrition and mortality in Bangladesh. Bulletin of the World Health Organization 1981; 59: 901–908.
16.Jamil, KM, et al. Micronutrients and anaemia. Journal of Health, Population and Nutrition 2008; 26: 340–355.
17.Hossain, S, et al. Single dose vitamin A treatment in acute shigellosis in Bangladesh children: randomised double blind controlled trial. British Medical Journal 1999; 316: 422–426.
18.Bennish, M, et al. Multiresistant Shigella infection in Bangladesh. Lancet 1985; 2: 441.
19.Ronsmans, C, Bennish, ML, Wierzba, T. Diagnosis and management of dysentery by community health workers. Lancet 1988; 2: 552–555.
20.Legros, D. Shigellosis: report of a workshop. Journal of Health, Population and Nutrition 2004; 22: 445–459.
21.Naheed, A, et al. Fluoroquinolone-resistant Shigella dysenteriae type 1 in northeastern Bangladesh. Lancet Infectious Diseases 2004; 4: 607–608.
22.Lee, WS, Puthucheary, SD. Species distribution and antibiotic resistance of shigella isolates in an urban community in Malaysia. Medical Journal of Malaysia 2003; 58: 262–267.
23.Sarkar, K, et al. Shigella dysenteriae type 1 with reduced susceptibility to fluoroquinolones. Lancet 2003; 361: 785.
24.Chu, YW, et al. Antimicrobial resistance in Shigella flexneri and Shigella sonnei, in Hong Kong, 1986 to 1995. Antimicrobial Agents and Chemotherapy 1997; 42: 440–443.
25.Rahman, M, et al. Detection of 4-quinolone resistance mutation in gyrA gene of Shigella dysenteriae type 1 by PCR. Antimicrobial Agents and Chemotherapy 1994: 38: 2488–2491.
26.Khan, WA, et al. Treatment of shigellosis: V. Comparison of azithromycin and ciprofloxacin. A double-blind, randomized, controlled trial. Annals of Internal Medicine 1997; 126: 697–703.
28.Black, RE, Brown, KH, Becker, S. Effects of diarrhea associated with specific enteropathogens on the growth of children in rural Bangladesh. Pediatrics 1984; 73: 799–805.
29.Hossain, MA, et al. Emergence and rapid spread of high level ciprofloxacine in Shigella species in urban and rural Bangladesh: an implication for therapy. 12th Annual Scientific Conference (ASCON XII), 9–12 February 2009 [Abstract]. Dhaka, Bangladesh. Dhaka, 2009, p. 180.